Literature DB >> 18008038

Iron, hepatitis C virus, and hepatocellular carcinoma: iron reduction preaches the gospel for chronic hepatitis C.

Naoki Fujita, Yoshiyuki Takei.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18008038     DOI： 10.1007/s00535-007-2110-4

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN： 0944-1174            Impact factor:   7.527


× No keyword cloud information.
  43 in total

1.  Long term effects of phlebotomy on biochemical and histological parameters of chronic hepatitis C.

Authors:  Motoyoshi Yano; Hisao Hayashi; Shinya Wakusawa; Fujiko Sanae; Toshikuni Takikawa; Yuhta Shiono; Motohiro Arao; Koji Ukai; Hiroshi Ito; Kazumasa Watanabe; Kentaro Yoshioka
Journal:  Am J Gastroenterol       Date:  2002-01       Impact factor: 10.864

Review 2.  The orchestration of body iron intake: how and where do enterocytes receive their cues?

Authors:  David M Frazer; Gregory J Anderson
Journal:  Blood Cells Mol Dis       Date:  2003 May-Jun       Impact factor: 3.039

Review 3.  Hepatocellular carcinoma and hepatitis C in the United States.

Authors:  Hashem B El-Serag
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

4.  Dietary iron restriction improves aminotransferase levels in chronic hepatitis C patients.

Authors:  Motoh Iwasa; Masahiko Kaito; Jiro Ikoma; Yoshinao Kobayashi; Yuji Tanaka; Kunihiro Higuchi; Keisuke Takeuchi; Kazuko Iwata; Shozo Watanabe; Yukihiko Adachi
Journal:  Hepatogastroenterology       Date:  2002 Mar-Apr

5.  Accumulation of 8-nitroguanine in the liver of patients with chronic hepatitis C.

Authors:  Shinichiro Horiike; Shosuke Kawanishi; Masahiko Kaito; Ning Ma; Hideaki Tanaka; Naoki Fujita; Motoh Iwasa; Yoshinao Kobayashi; Yusuke Hiraku; Shinji Oikawa; Mariko Murata; Jinyan Wang; Reiji Semba; Shozo Watanabe; Yukihiko Adachi
Journal:  J Hepatol       Date:  2005-09       Impact factor: 25.083

6.  Association between reactive oxygen species and disease activity in chronic hepatitis C.

Authors:  N De Maria; A Colantoni; S Fagiuoli; G J Liu; B K Rogers; F Farinati; D H Van Thiel; R A Floyd
Journal:  Free Radic Biol Med       Date:  1996       Impact factor: 7.376

7.  Hepatic iron accumulation is associated with disease progression and resistance to interferon/ribavirin combination therapy in chronic hepatitis C.

Authors:  Naoki Fujita; Ryosuke Sugimoto; Naohito Urawa; Jun Araki; Rumi Mifuji; Mika Yamamoto; Shinichiro Horiike; Hideaki Tanaka; Motoh Iwasa; Yoshinao Kobayashi; Yukihiko Adachi; Masahiko Kaito
Journal:  J Gastroenterol Hepatol       Date:  2007-11       Impact factor: 4.029

8.  Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C.

Authors:  Naoki Fujita; Ryosuke Sugimoto; Masaki Takeo; Naohito Urawa; Rumi Mifuji; Hideaki Tanaka; Yoshinao Kobayashi; Motoh Iwasa; Shozo Watanabe; Yukihiko Adachi; Masahiko Kaito
Journal:  Mol Med       Date:  2007 Jan-Feb       Impact factor: 6.354

9.  Serum aminotransferase levels as an indicator of the effectiveness of venesection for chronic hepatitis C.

Authors:  H Hayashi; T Takikawa; N Nishimura; M Yano
Journal:  J Hepatol       Date:  1995-03       Impact factor: 25.083

10.  Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells.

Authors:  D Sakamuro; T Furukawa; T Takegami
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103
View more
  6 in total

Review 1.  Crossing the Iron Gate: Why and How Transferrin Receptors Mediate Viral Entry.

Authors:  Marianne Wessling-Resnick
Journal:  Annu Rev Nutr       Date:  2018-05-31       Impact factor: 11.848

Review 2.  Viral hepatocarcinogenesis.

Authors:  W-L Tsai; R T Chung
Journal:  Oncogene       Date:  2010-03-15       Impact factor: 9.867

Review 3.  Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples.

Authors:  Douglas B Kell
Journal:  Arch Toxicol       Date:  2010-08-17       Impact factor: 5.153

4.  Serum Iron Levels Decreased in Patients with HBV-Related Hepatocellular Carcinoma, as a Risk Factor for the Prognosis of HBV-Related HCC.

Authors:  Yanyan Wei; Wei Ye; Wei Zhao
Journal:  Front Physiol       Date:  2018-02-06       Impact factor: 4.566

Review 5.  Iron at the Interface of Hepatocellular Carcinoma.

Authors:  Rossana Paganoni; André Lechel; Maja Vujic Spasic
Journal:  Int J Mol Sci       Date:  2021-04-15       Impact factor: 5.923

Review 6.  Ferroptosis in viral infection: the unexplored possibility.

Authors:  Mao-Peng Wang; Banda Joshua; Ning-Yi Jin; Shou-Wen Du; Chang Li
Journal:  Acta Pharmacol Sin       Date:  2021-12-06       Impact factor: 7.169
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.